JPRN-UMIN000040188已完成未知
Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial - Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial
Yokohama City University School of Medicine0 个研究点目标入组 2,063 人开始时间: 2020年4月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,063
研究概览
简要总结
Please see: J Thorac Dis. 2021 Jan;13(1):202-212.
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; a randomised, placebo-controlled prophylaxis study (COPCOV)Profliaxis of SARS-CoV-2 infectionMedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862EUCTR2020-001441-39-ITIVERSITY OF OXFORD40,000
进行中（未招募）
1 期
Chloroquine/ hydroxychloroquine prevention of COVID-19 (COPCOV)EUCTR2020-001441-39-GBniversity of Oxford10,000
已完成
4 期
Hydroxychloroquine real world efficacy assessment as add on therapy compare to gliptin in IndiaCTRI/2018/06/014382Patna Medical College2,000
进行中（未招募）
1 期
Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Nonsmall cell lung cancerPatients affected by Resectable Head and Neck (HN) cancer (only Squamous Cell Carcinoma of the oral cavity or larynx), or Resectable Non-small cell lung cancer (NSCLC, only Lung Squamous Cell Carcinoma or Adenocarcinoma).CTIS2024-516189-12-00Ospedale San Raffaele S.r.l.20
进行中（未招募）
1 期
Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Non-small cell lung cancerEUCTR2021-004189-37-ITOSPEDALE SAN RAFFAELE20